MetaCap

McKesson Corporation (MCK)

NYSE: MCKHealth CareOther PharmaceuticalsUSD

1,069.43+7.27 (+0.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MCK stock chart

Technical analysis

Key statistics

All statistics
Market cap
$123.47B
EPS (TTM)
$38.77
Dividend yield
0.32% ($3.40)
Ex-dividend date
Sep 1, 2026
52-week range
723.68 – 1,121.50
Day range
1,067.43 – 1,088.14
Volume / Avg
869.45K / 790.59K
Beta
—

52-week range

$723.68$1,121.50

MCK stock today

McKesson (MCK) closed at $1,069.43 on Nov 20, up 0.68% (+$7.27), versus the S&P 500's 3.70% decline. Shares are 4.6% below their 52-week high of $1,121.50, set on Nov 5, 2026 and 47.8% above the 52-week low of $723.68, near the top of the past year's range. MCK is up 30.4% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 23.5%.

At 27.6x trailing earnings, McKesson trades above the peer-group median of 18.9x. Its forward P/E of 20.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. McKesson pays an annual dividend of $3.40 per share, a 0.32% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About McKesson

Company profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers.

Industry
Other Pharmaceuticals
CEO
Mr. Brian S. Tyler Ph.D.
Headquarters
Irving, TX
Employees
41,600

Financial highlights

Full financials

In fiscal 2026, McKesson generated $403.43 billion in revenue, up 12.4% from fiscal 2025, its 13th consecutive year of revenue growth. Net income was $4.76 billion (+44.5% year over year), for a net margin of 1.2% versus a median of 0.9% in the prior 5 years. Gross margin was 3.6% (down from 3.7%) and operating margin 1.5%.

McKesson annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$403.43B$359.05B$308.95B$276.71B$263.97B
Growth+12.36%+16.22%+11.65%+4.83%+10.80%
Net income$4.76B$3.29B$3.00B$3.56B$1.11B
EPS (diluted)$38.38$25.72$22.39$25.03$7.23

Analyst forecast

Forecast

Consensus (16 analysts)

buy

Avg. price target

$1,161.07+8.57%

  • Strong buy 3
  • Buy 10
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $965.00High $1,260.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$10.44 vs $10.69
Surprise
-2.34%

Dividends

Dividend history
Annual dividend
$3.40
Last payment
$0.94
Ex-dividend date
Sep 1, 2026

MCK news

All MCK news

McKesson peers

Health Care sector
MCK peer companies
CompanyPrice% ChgMarket capCompare
CORCencora Inc.339.09-0.63%$64.71Bvs MCK
CAHCardinal Health Inc.272.81+0.17%$63.06Bvs MCK
HLFHerbalife Ltd.15.53-0.26%$1.63Bvs MCK
NUSNu Skin Enterprises Inc.3.80+0.80%$184.98Mvs MCK
ESYNEnerSyn Global Inc.1.11-0.89%$37.44Mvs MCK
COSMCosmos Health Inc.2.81-2.09%$14.14Mvs MCK
MEDSDataMeds AI Inc.1.34+84.14%$7.67Mvs MCK
HKPDCellyan Biotechnology Co. Ltd Class A1.38+2.60%$3.40Mvs MCK

Indexes, lists and sector

McKesson stock FAQ

What is McKesson's stock price today?

MCK last traded at $1,069.43 as of Nov 20, 4:00 PM EST, up 0.68% on the day. Prices are delayed at least 15 minutes.

Does McKesson pay a dividend?

Yes. McKesson pays $3.40 per share annually, a 0.32% yield. The most recent dividend of $0.94 had an ex-dividend date of Sep 1, 2026.

What is MCK's P/E ratio?

MCK trades at a trailing P/E ratio of 27.58 and a forward P/E of 20.39, compared with a median of 18.9 for its closest peers.

Is McKesson in the S&P 500?

Yes. McKesson (MCK) is a constituent of the S&P 500 index.

Who is McKesson's CEO?

Mr. Brian S. Tyler Ph.D. is the chief executive officer of McKesson Corporation, which has about 41,600 employees.

Has MCK ever split its stock?

Yes. The most recent MCK stock split was a 2-for-1 split on Jan 5, 1998.

What is the MCK 52-week high?

The 52-week high for MCK is $1,121.50 and the 52-week low is $723.68. The stock is currently 4.6% below its high.

Compare MCK